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Abstract
Francisella tularensis is a bacterial pathogen that uses host-derived PGE2 to subvert the host’s adaptive immune responses in
multiple ways. Francisella-induced PGE2 acts directly on CD4 T cells to blunt production of IFN-c. Francisella-induced PGE2
can also elicit production of a .10 kDa soluble host factor termed FTMØSN (F. tularensis macrophage supernatant), which
actsonIFN-cpre-activatedMØtodown-regulateMHCclassIIexpressionviaaubiquitin-dependentmechanism,blockingantigen
presentation to CD4 T cells. Here, we report that FTMØSN-induced down-regulation of MØ class II is the result of the induction of
MARCH1, and that MØ expressing MARCH1 ‘‘resistant’’ class II molecules are resistant to FTMØSN-induced class II down-
regulation. Since PGE2 can induce IL-10 production and IL-10 is the only reported cytokine able to induce MARCH1 expression in
monocytes and dendritic cells, these findings suggested that IL-10 is the active factor in FTMØSN. However, use of IL-10 knockout
MØ established that IL-10 is not the active factor in FTMØSN, but rather that Francisella-elicited PGE2 drives production of a
.10 kDa host factor distinct from IL-10. This factor then drives MØ IL-10 production to induce MARCH1 expression and the
resultant class II down-regulation. Since many human pathogens such as Salmonella typhi, Mycobacterium tuberculosis and
Legionella pneumophila also induce production of host PGE2, these results suggest that a yet-to-be-identified PGE2-inducible host
factor capable of inducing IL-10 is central to the immune evasion mechanisms of multiple important human pathogens.
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Introduction
F. tularensis is a bacterial pathogen that infects macrophages and
uses host-derived PGE2 to enhance bacterial growth and subvert
the adaptive immune response [1]. Other clinically relevant
human pathogens such as Salmonella typhi [2,3], Mycobacterium
tuberculosis [4] and Legionella pneumophila [5] also elicit host PGE2,
and thus may employ a similar strategy to promote infection.
Francisella-induced PGE2 acts directly on CD4 T cells, re-
programming them to restrict production of anti-Francisella
cytokines such as interferon-c (IFN-c) [1]. Moreover, blockade
of Francisella-induced PGE2 production in vivo allows for more
robust IFN-c production and better control of pulmonary
Francisella infection in mice [6].
Francisella-induced PGE2, which is elicited by either the live
vaccine strain (LVS) or human virulent SchuS4 strain of
Francisella, also acts in an autocrine/paracrine fashion to drive
production of a soluble MØ factor that elicits the ubiquitin-
dependent down-regulation of MHC class II and CD86 molecules
expressed by IFN-c activated MØ [7] (Figure 1). The factor within
this F. tularensis MØ supernatant (termed FTMØSN, pronounced
foo ˇt-mo ¯-sin) drives MØ class II down-regulation by eliciting
ubiquitination of the class II cytoplasmic tail, which results in class
II trafficking to degradative intracellular compartments [7,8]. The
resulting class II negative MØ are thus greatly impaired in their
ability to present antigens to CD4 T cells.
Until now, the identity of the active factor in FTMØSN and the
mechanism of class II ubiquitination were unknown. Here, we
establish that the mechanism of FTMØSN induced class II
ubiquitination is via up-regulation of the ubiquitin ligase
MARCH1. Studies with IL-10 knockout (IL-10D) MØ revealed
that Francisella (via elicitation of PGE2) is inducing production of
a yet-to-be identified factor that is able to elicit MØ IL-10
production to then induce MØ class II down-regulation via a
MARCH1-dependent mechanism.
Methods
Ethics Statement
Mice were house and used in strict accordance to the guidelines
established by the Albany Medical College Institutional Animal
Care and Use Committee. Animal protocols were reviewed and
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Care and Use Committee (Protocol # 603276).
Generation of Bone Marrow-Derived Macrophages
Producer bone marrow-derived macrophages (BMMØ –
Figure 1) were generated from B10.Br, C57Bl/6 or IL-10D (on
the C57Bl/6 background [9]) mice as previously described [7].
Reporter BMMØ from B10.Br, MARCH1D [10], class II K.R
[11] or IL-10D [9] mice were treated with 100 U/ml IFN-c for
24 hours and then washed before exposure to FTMØSN or
control supernatants.
Measurement of IL-10
IL-10 was measured by cytometric bead array (CBA, BD
Biosciences, San Jose, CA catalog number 558300) IL-10 Flex Set
according to the manufacturer’s directions.
Treatment of BMMØ with FTMØSN
FTMØSN was generated by exposure of producer BMMØ to
F. tularensis LVS at an multiplicity of infection of 100:1 (Ft:MØ) as
previously described [7]. FTMØSN was cleared of any bacteria
and cellular debris by centrifugation and 0.2 mm filtration.
Reporter MØ were exposed to 50% FTMØSN or control
supernatants for 20–24 hours before washing and harvesting to
generate whole cell lysates. The anti-IL-10 receptor blocking mAb
1B1.3A (BioXCell # BE005) was used at the indicated concen-
tration.
Western Blot Analysis of MØ MHC Class II Levels
Whole cell lysates of treated or control BMMØ were analyzed
for total MHC class II levels by SDS-PAGE and anti-class II b
chain western blot as previously reported [7]. Blots were
subsequently probed for GAPDH as a loading control.
RT-PCR Analysis of MARCH1 mRNA Levels
Total RNA was prepared using TRIzol (Invitrogen) and treated
with DNase I to remove genomic DNA. RNA was converted to
cDNA using standard procedures and reagents from Invitrogen.
Real-time PCR primers used to amplify MHC class II and
MARCH1 have been described previously [12] and primers for
GAPDH were from Qiagen (QuantiTect primer #QT01658692).
Real-time PCR was performed using an ABI Prism 7900HT
Sequence detection system and QuantiTect SYBR green PCR kit
(QIAGEN) according to the manufacturers instructions. In all
experiments the normalized Ct values for the FTMØSN–treated
macrophages were expressed relative to the normalized Ct values
for the mock supernatant-treated macrophages.
Results
The Ubiquitin Ligase MARCH1 is Responsible for
FTMØSN-induced Down-regulation of Macrophage Class
II Expression
Previous work established that upon Francisella infection, MØ
make PGE2, which works in an autocrine/paracrine fashion to
elicit the production of a .10 kDa soluble factor termed
FTMØSN. FTMØSN drives the ubiquitin-dependent down-
regulation of MHC class II expressed by IFN-c pre-activated
reporter MØ (Figure 1 and [7]). The goal of this report is to define
the mechanism of class II down-regulation and characterize the
active factor in FTMØSN.
One mechanism for the post-translational control of MHC class
II expression in MØ and dendritic cells (DC) is the regulated
expression of the ubiquitin ligase MARCH1, which ubiquitinates
the cytoplasmic domain of class II molecules resulting in their
intracellular sorting to degradative intracellular compartments
[13,14]. To determine if MARCH1 might be involved in
FTMØSN-elicited down-regulation of class II, the effect of
FTMØSN treatment on reporter MØ MARCH1 mRNA levels
was determined (Figure 2). Overnight treatment of IFN-c pre-
activated reporter MØ with FTMØSN results in the up-regulation
of MARCH1 mRNA, but no significant change in the level of Ab
class II mRNA expression, consistent with a post-transcriptional
mechanism for regulating MHC class II expression. The current
lack of reliable anti-MARCH1 antibodies precludes direct analysis
of the impact of FTMØSN treatment on MARCH1 protein levels.
Nevertheless, the results presented in Figure 2 suggest that
FTMØSN-induced up-regulation of MARCH1 may be responsi-
ble for the ubiquitin-dependent down-regulation of MHC class II
molecules observed in FTMØSN treated MØ [7].
To further investigate this possibility, the level of class II
expression by FTMØSN-treated wild type and MARCH1D
reporter MØ was determined (Figure 3). The results show that
MARCH1D MØ are completely refractory to the class II down-
regulatory effects of FTMØSN, confirming the notion that
FTMØSN-induced MARCH1 drives class II down-regulation.
To further confirm this scenario and determine if class II is a direct
target for MARCH1-mediated ubiquitination, the impact of
FTMØSN treatment on class II expression by reporter MØ
expressing class II molecules lacking the single cytoplasmic lysine
ubiquitination site (i.e., Ab K225R [11]) was examined (Figure 3).
Consistent with the idea that class II is the direct target for
MARCH1-mediated ubiquitination, MARCH1-positive MØ ex-
pressing these non-ubiquitinatable class II molecules are refractory
to FTMØSN-induced MHC class II down-regulation. Taken
together, the results presented in Figures 2 and 3 establish that
MARCH1-mediated ubiquitination of the cytoplasmic tail of class
II b chains is directly responsible for the FTMØSN-induced
down-regulation of reporter MØ MHC class II expression [7].
FTMØSN Contains a Soluble Factor the Induces MØ IL-10
Production
IL-10 is the only cytokine that has been demonstrated to induce
MARCH1 expression in both DC and human monocytes [13,14].
Figure 1. FTMØSN Production and Action. F. tularensis infected
‘‘producer’’ MØ make PGE2, which acts in an autocrine/paracrine fashion
to drive the production of FTMØSN (F. tularensis MØ supernatant).
FTMØSN contains a soluble factor of .10 kDa molecular mass that
elicits the ubiquitin-dependent down-regulation of ‘‘reporter’’ MØ MHC
class II molecules [7]. In this report, we establish that the active factor in
FTMØSN is distinct from IL-10, but that ‘‘reporter’’ MØ class II down-
regulation is driven by induction of reporter MØ IL-10 production, which
drives MARCH1 expression and class II ubiquitination. This means that
FTMØSN contains a factor distinct from IL-10, which is induced by F.
tularensis-elicited PGE2 and which is able to drive reporter MØ IL-10
production.
doi:10.1371/journal.pone.0037330.g001
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IL-10 [15] and FTMØSN contains some level of IL-10 (see
below). Together, this suggests that IL-10 is likely the PGE2-
induced factor in FTMØSN responsible for inducing MØ
MARCH1 expression. To test this possibility, the ability of
FTMØSN generated from both wild type and IL-10D ‘‘producer’’
MØ (Figure 1) to drive MHC class II down-regulation by wild type
reporter MØ was determined (Figure 4). Surprisingly, FTMØSN
from both wild type and IL-10D producer MØ drive the same
degree of reporter MØ MHC class II down-regulation, demon-
strating that the active factor in FTMØSN is not IL-10 (The
absence of IL-10 in FTMØSN generated by IL10D BMMØ was
confirmed by CBA, see below).
The ability of FTMØSN from IL-10D producer MØ to drive
MHC class II down-regulation either means that FTMØSN
contains a factor distinct from IL-10 that is able to elicit MARCH1
expression and drive class II down-regulation or that the active
factor in FTMØSN acts by inducing IL-10 production by reporter
MØ which then induces MARCH1 expression and class II down-
regulation. To determine which of these scenarios is correct,
BMMØ from IL-10D mice were used as reporter MØ (Figure 5).
IL-10D reporter MØ fail to down-regulate MHC class II
expression in response to either wild type or IL-10D FTMØSN,
whereas wild type reporter MØ down-regulate class II in response
to both forms of FTMØSN. These results indicate that IL-10
produced by reporter MØ is central to FTMØSN’s ability to
induce class II down-regulation.
Consistent with the possibility that FTMØSN is acting through
induction of IL-10, analysis of both FTMØSN and secondary
supernatants from FTMØSN-treated reporter MØ revealed that
these secondary supernatants contain approximately 10 fold more
IL-10 than FTMØSN itself (Figure 6). Moreover, treatment of
reporter MØ with high dose recombinant IL-10 (100 ng/ml)
results in down-regulation of MØ class II (Figure 7), whereas lower
doses of recombinant IL-10 had a limited effect on MØ class II
Figure 2. FTMØSN Induces Increased Reporter MØ MARCH1
mRNA Expression. IFN-c pre-activated ‘‘reporter’’ BMMØ were treated
with FTMØSN or mock SN for 24 hours. Cells were harvested and
MARCH1 (panel A) or MHC class II b chain (panel B) mRNA levels
determined by RT-PCR and normalized to GAPDH. Results are reported
as FTMØSN-induced change in mRNA expression compared to mock SN
treated MØ (+/21 S.E.M). p values were determine by a student’s t test.
n=3.
doi:10.1371/journal.pone.0037330.g002
Figure 3. MARCH1D and Class II K225R BMMØ Fail to Down-
Regulate Class II in Response to FTMØSN. IFN-c activated wild
type (WT), MARCH1D (M1D) or class II K225R (K.R) BMMØ were treated
with mock SN or FTMØSN. After 20–24 hours, total MØ class II (II) and
GAPDH (G) levels were determined by western blot analysis of whole
cell lysates [7]. Shown are representative results from 1 of 3
independent experiments.
doi:10.1371/journal.pone.0037330.g003
Figure 4. FTMØSN from IL-10 Knockout MØ Down Regulates
Reporter MØ MHC Class II. Wild type (WT) and IL-10 knockout (IL-
10D) BMMØ were treated with media or F. tularensis LVS to generate
mock SN or FTMØSN, respectively. The resulting SN was added to IFN-c
activated B10.Br reporter MØ and after an overnight culture the levels
of total MHC class II (II) and GAPDH (G) was monitored by SDS-PAGE
and western blotting [7]. Shown are representative results from 1 of 3
independent experiments.
doi:10.1371/journal.pone.0037330.g004
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with a blocking anti-IL-10 receptor mAb blocks FTMØSN-
induced class II down-regulation (Figure 8). Taken together, these
results indicate that FTMØSN contains a PGE2-inducible factor
distinct from IL-10 that acts to induce IL-10 release by reporter MØ.
This reporter MØ-produced IL-10 then acts in an autocrine/
paracrine fashion to induce MARCH1 expression to drive
ubiquitin-dependent MHC class II down-regulation.
Discussion
Previous studies have established that Francisella tularensis-
infected MØ produce PGE2, which can both alter CD4 T cell
cytokine production and drive the production of a soluble factor
(i.e., FTMØSN) that elicits the ubiquitin-dependent down-
regulation of MØ MHC class II expression [7]. Since other
clinically relevant human pathogens such as Salmonella typhi [2,3],
Mycobacterium tuberculosis [4] and Legionella pneumophila [5] also elicit
host PGE2, it was of interest to determine the mechanism of
FTMØSN-induced MØ class II down-regulation.
Post-translation control of MHC class II expression in DC and
MØ can be driven by MARCH1-mediated ubiquitination of the
cytoplasmic tail of class II molecules [13,14], which results in
altered intracellular class II trafficking away from recycling
endosomes and toward degradative compartments [8]. To date,
IL-10 is the only cytokine reported to induce antigen presenting
cell MARCH1 expression and class II down-regulation [13,14].
Since PGE2 can induce MØ IL-10 [13], we explored the
possibility that a PGE2 to IL-10 to MARCH1 axis is responsible
for the FTMØSN-induced down-regulation of reporter MØ class
II expression (Figure 1).
Analysis of reporter MØ exposed to FTMØSN revealed that
they up-regulate MARCH1 mRNA expression. In addition,
MARCH1D MØ fail to down-regulate class II expression in
response to FTMØSN. Finally, MØ expressing class II molecules
refractory to the action of MARCH1 (i.e., I-A b chain K225R
[11]) fail to down-regulate class II in response to FTMØSN.
Taken together, these results establish that the active factor in
FTMØSN drives the ubiquitin-dependent down-regulation of MØ
class II by increasing MØ MARCH1 expression, which results in
the ubiquitination of the cytoplasmic domain of class II and its
post-endocytic sorting into a degradative compartment.
To address the question of whether the MARCH1-inducing
factor in FTMØSN is IL-10, IL-10D producer MØ were exposed
Figure 5. IL-10 Knockout Reporter MØ Fail to Down Regulate
Class II in Response to FTMØSN. FTMØSN from wild type (WT) and
IL-10D BMMØ was used to treat either WT (upper two panels) or IL-10D
(lower two panels) reporter MØ. Reporter MØ were also treated with
either media alone or supernatant from non-infected MØ (Mock). After
overnight culture, the levels of class II (II) and GAPDH (G) was monitored
as in Figure 4. Shown are representative results from 1 of 3 independent
experiments.
doi:10.1371/journal.pone.0037330.g005
Figure 6. FTMØSN Induces Reporter MØ IL-10 Production. The level of IL-10 in the following samples was determined by cytometric bead
array; FTMØSN from WT or IL-10D producer MØ (FTMØSN or IL-10D FTMØSN) as well as secondary SN from the indicated reporter MØ treated (Tx)
with the indicated form of FTMØSN. Shown is the average level of IL-10 in each sample (+/21 S.E.M.). n=3 for all samples except those involving the
use of IL-10D MØ, where n=2 . ND=not detected. The IL-10 in the secondary SN of IL-10D MØ treated with WT FTMØSN is likely carry-over from the
WT FTMØSN.
doi:10.1371/journal.pone.0037330.g006
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Surprisingly, FTMØSN from IL-10 knockout MØ is able to drive
reporter MØ class II down-regulation, ruling out IL-10 as the
active factor in FTMØSN. In contrast, IL-10D reporter MØ fail to
down-regulate class II in response to FTMØSN (both wild type
and IL-10D FTMØSN). These results indicate that PGE2 is
inducing IL-10 via an indirect mechanism. More precisely, PGE2
is inducing the production of a .10 kDa soluble factor distinct from
IL-10 (i.e. the active factor in FTMØSN), which then acts to
induce reporter MØ IL-10 production, driving MARCH1
expression and class II down-regulation. While previous reports
have demonstrated that PGE2 can induce IL-10 production by
MØ and DC [15,16], the molecular mechanism of IL-10
induction remains undetermined. These current findings suggest
a complex mechanism, minimally involving the production of at
least one yet to be defined soluble factor. These results also suggest
that Francisella might act to control MØ responsiveness to this
undefined soluble factor, since Francisella-infected producer MØ
(which are bathed in FTMØSN) do not make as much IL-10 at
non-infected reporter MØ exposed to FTMØSN. This possibility
will be addressed in future studies.
Presently, the identity of the IL-10-inducing active factor in
FTMØSN remains unclear. Preliminary experiments using either
knockout MØ and/or neutralizing mAbs have ruled out TGF-b,
IL-6, VEGF, MIP-1a and leukemia inhibitory factor. Moreover,
generation of supernatants from Francisella–infected gene knock-
out producer MØ has established that production of FTMØSN
activity is independent of TLR-2 (which recognizes F. tularensis-
derived lipoproteins [17]) and MØ caspase-1 activity (which drives
IL-1b production/release). Therefore, it is likely that a combined
genomics/proteomics approach will be necessary to conclusively
identify and characterize the PGE2-induced active factor in
FTMØSN that elicits MØ IL-10 expression to then drive MØ
class II down-regulation.
MHC class II restricted antigen presentation by MØ is central
to immune defense against many human pathogens and tumors.
Moreover, many human pathogens and tumors elicit the
production of significant levels of PGE2. The results presented in
this report establish that PGE2 drives the production of a soluble
MØ factor distinct from IL-10 that induces MØ IL-10 production to
drive MARCH1 expression, culminating in down-regulation of
MØ class II molecules and limiting the ability of these cells to
participate in an adaptive immune response. Future identification
of the active factor in FTMØSN will provide greater insight into
this mechanism of immune suppression common to both infectious
agents and tumors, and will provide an additional target for new
interventional therapies.
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